The Wharton Moneyball Post Game Podcast


Wharton Moneyball: 2019 NBA Finals, NFL Offensive Linemen, & TrackMan Data in MLB

Ep. 154

Show from 6/12/19

Full house in this episode of Wharton Moneyball! At the top of the show our hosts get into the biggest sports news of the week, the NBA finals, Durant's injury and the Warriors victory in Toronto. Then former NFL Offensive Lineman turned MIT PHD in Mathematics, John Urschel, joins the show to talk about how he used his intelligence to help him excel on and off the field as well as his brand new book, “Mind and Matter: A Life in Math and Football.” Plus learn how TrackMan data in the MLB is useful in player development.


John Urschel - Former offensive lineman for the Baltimore Ravens and a PhD candidate at MIT. He has a bachelor’s and master’s degree in mathematics from Penn State, and in 2013, he won the Sullivan Award, given to “the most outstanding amateur athlete in the United States,” and the Campbell Trophy, awarded to the country’s top scholar-athlete in college football. He is also the Author of the new book, “Mind and Matter: A Life in Math and Football.”

Follow him on Twitter: @JohnCUrschel

Check out his book:

John Olshan - General Manager of TrackMan, a technology used by all 30 MLB teams today.

Follow TrackMan on Twitter: @TrackManBB

Visit TrackMan Sites:

Zach Day - Former Major League Pitcher and he is now the Manager of Insights and Player Development at TrackMan.

More Episodes


7/22/2020: COVID-19, Sports, David Fajgenbaum

David Fajgenbaum, MD, MBA, MSc is a groundbreaking physician-scientist, disease hunter, and bestselling author of the acclaimed memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action. Fajgenbaum went from being a beast-like college Quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, he spearheaded an innovative approach to research and discovered a possible treatment that has put him into an extended remission. Now, he is spreading this approach to advance cures for other diseases and sharing lessons he learned about living from nearly dying through Chasing My Cure.One of the youngest individuals ever appointed to the faculty at Penn Medicine and the top 1 percent youngest grant awardees of a leading NIH grant, Dr. Fajgenbaum is co-founder and executive director of the Castleman Disease Collaborative Network (CDCN) and Associate Director, Patient Impact, for the Penn Orphan Disease Center. He has been recognized on the Forbes 30 Under 30 list, as a top healthcare leader by Becker's Hospital Review, the Global Genes RARE Champion of Hope: Science awardee, and one of three recipients--including Vice President Joe Biden--of a 2016 Atlas Award from the World Affairs Council of Philadelphia. Before co-founding the CDCN, Dr. Fajgenbaum co-founded and led the Actively Moving Forward Support Network, a non-profit organization dedicated to supporting grieving college students. Dr. Fajgenbaum has been profiled in a cover story by The New York Times as well as by Good Morning America, CNN, and the Today Show, among others.Dr. Fajgenbaum earned a BS from Georgetown University magna cum laude with honors and distinction, MSc from the University of Oxford, MD from the University of Pennsylvania Medical School, and MBA from The Wharton School. He is a former Division I college quarterback, state-champion weight lifter, and co-founder of a national grief support network.